In turn, we hypothesize that BET proteins such as BRD4 regulate MDSC functions, and subsequent pharmacological inhibition of BRD4 will alleviate MDSC-mediated immune suppression in CLL. The gene discussed is BRD4; the disease is B-cell chronic lymphocytic leukemia.